President Trump introduces $50 billion tariffs on Chinese products and new limits on Chinese high-tech investments in America.

Apple Boston

2018-05-25 07:30:00 Fri ET

President Trump introduces $50 billion tariffs on Chinese products and new limits on Chinese high-tech investments in America.

This new round of tariffs arises as a major macro surprise less than a fortnight after Treasury Secretary Steve Mnuchin says the Sino-U.S. trade war is on hold.

China has already committed to significantly increasing its main purchases of U.S. goods and services in order to reduce their trade imbalance.

President Trump vows to impose tariffs on another $200 billion Chinese imports if the communist regime cannot comply with fair bilateral trade practices.

The Chinese Xi administration may choose to postpone unfair Sino-American trade negotiations after the November 2018 U.S. mid-term elections.

However, the Trump administration aims to attain a hefty $200 billion reduction in bilateral trade deficit.

In addition to the Sino-U.S. trade war, the Trump team announces 25% steel tariffs and 10% aluminum tariffs on Canada, Europe, and Mexico.

The Trump administration seems to consider this deliberate trade tactic part of the political path toward the median voter with better midterm election results.

Many western allies and East Asian dragon economies plan to voice their concerns and complaints at the World Trade Organization (WTO) international tribunal.

 


If any of our AYA Analytica financial health memos (FHM), blog posts, ebooks, newsletters, and notifications etc, or any other form of online content curation, involves potential copyright concerns, please feel free to contact us at service@ayafintech.network so that we can remove relevant content in response to any such request within a reasonable time frame.

Blog+More

Global debt surges to $250 trillion in the fiscal year 2019.

Olivia London

2019-12-28 09:36:00 Saturday ET

Global debt surges to $250 trillion in the fiscal year 2019.

Global debt surges to $250 trillion in the fiscal year 2019. The International Institute of Finance analytic report shows that both China and the U.S. accou

+See More

China turns on its 5G telecom networks in the hot pursuit of global tech supremacy.

Becky Berkman

2019-12-07 11:30:00 Saturday ET

China turns on its 5G telecom networks in the hot pursuit of global tech supremacy.

China turns on its 5G telecom networks in the hot pursuit of global tech supremacy. China Telecom, China Unicom, and China Mobile disclose 5G fees of $18-$2

+See More

The business legacy of Steve Jobs transforms smart mobile devices with Internet connectivity and digital content.

Becky Berkman

2020-03-19 13:39:00 Thursday ET

The business legacy of Steve Jobs transforms smart mobile devices with Internet connectivity and digital content.

The business legacy and sensitivity of Steve Jobs can transform smart mobile devices with Internet connectivity, music and video content curation, and digit

+See More

Is Bitcoin a legitimate (crypto)currency or a new bubble waiting to implode?

Monica McNeil

2017-11-24 08:41:00 Friday ET

Is Bitcoin a legitimate (crypto)currency or a new bubble waiting to implode?

Is Bitcoin a legitimate (crypto)currency or a new bubble waiting to implode? As its prices skyrocket, bankers, pundits, and investors increasingly take side

+See More

Our proprietary alpha investment model outperforms most stock market indexes from 2017 to 2025.

James Campbell

2025-02-02 11:28:00 Sunday ET

Our proprietary alpha investment model outperforms most stock market indexes from 2017 to 2025.

Our proprietary alpha investment model outperforms most stock market indexes from 2017 to 2025. Our proprietary alpha investment model outperforms the ma

+See More

Several pharmaceutical companies now switch their primary focus from generic prescription drugs to medical specialties.

Rose Prince

2018-10-15 09:33:00 Monday ET

Several pharmaceutical companies now switch their primary focus from generic prescription drugs to medical specialties.

Several pharmaceutical companies now switch their primary focus from generic prescription drugs to medical specialties such as cardiovascular medications an

+See More